© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
Americas Committee for Treatment and Research in Multiple Sclerosis
Personalized Cladribine Dosing for Multiple Sclerosis
April 15, 2021
Kimberly Allen-Philbey, a PhD candidate at the Barts MS Center in London, discussed the advantages of using a personalized dosing schedule of off-label, subcutaneous cladribine.
Finding New Therapeutic Targets in MS: Daniel Reich, MD, PhD
April 14, 2021
The senior investigator at the National Institutes of Neurological Disorders and Stroke spoke about further research his lab is conducting into MS mechanisms.
Treating Paramagnetic Rim Lesions in Multiple Sclerosis
April 13, 2021
Jemima Akinsanya, DO, Neuroimmunology Clinical Fellow at the National Institutes of Health, discussed new studies of anakinra and tolebrutinib in MS.
Understanding Mechanisms of MS Chronic Inflammation: Jemima Akinsanya, DO, and Daniel Reich, MD, PhD
April 09, 2021
The duo from the National Institutes of Health discussed how monitoring and treating paramagnetic rim lesions can improve patient care in multiple sclerosis.
Chariot MS Study of Off-Label Cladribine in Advanced MS: Kimberly Allen-Philbey
April 06, 2021
The PhD candidate at the Barts MS Center in London discussed the upcoming Chariot MS study as well as further research she would like to conduct in personalized cladribine dosing.
Ways to Lower Genetic Leukodystrophies Misdiagnosis in Clinical Settings: Alise Carlson, MD
April 06, 2021
Alise Carlson, MD, a resident at Cleveland Clinic, provided insight on how raising awareness for genetic leukodystrophies may ultimately improve misdiagnosis rates.
7-Tesla MRI Use in Research: Jemima Akinsanya, DO, and Daniel Reich, MD, PhD
March 31, 2021
The duo from the National Institutes of Health discussed the advantages of the ultra-high resolution imaging technology in research.
Expanding Research on MS Diagnosis Disclosure and Long-Term Impacts: Anne Kever, PhD
March 31, 2021
The postdoctoral researcher at Columbia University discussed the long-term plans to gain a better understanding of MS diagnosis disclosure and how it can impact other qualities of life.
CNS Demyelination and Autoimmune Neurology: Spencer Hutto, MD
March 30, 2021
The fellow of autoimmune neurology at Massachusetts General Hospital also discussed concerns of associations between multiple sclerosis and COVID-19.
Off-Label, Personalized Cladribine Dosing: Kimberly Allen-Philbey
March 29, 2021
The PhD candidate at the Barts MS Center in London discussed her study presented at ACTRIMS Forum 2021 that evaluated CPD in patients with relapsing MS.